Comparison of Ultrasound-Guided Lumbar ESPB and ABB for Knee Arthroplasty
Launched by BURSA CITY HOSPITAL · Aug 4, 2025
Trial Information
Current as of November 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of nerve blocks to help manage pain after knee replacement surgery, which is often quite painful. One method, called the Adductor Canal Block (ACB), is already used to reduce pain after this surgery. The other, called the Erector Spinae Plane Block (ESPB), is a newer technique being studied to see if it might work better or just as well as the ACB. The goal is to find out which nerve block helps patients feel more comfortable after their knee surgery.
People who might take part in this study are adults who have had total knee replacement surgery and are generally healthy enough for surgery (classified as ASA I or II, meaning they have no or mild health problems). Some people won’t be able to join, including those who have bleeding problems, allergies to local anesthetics, serious liver or kidney issues, infections where the injection would be given, or who are pregnant or breastfeeding. If you participate, you can expect to receive one of the two nerve block treatments after surgery to manage pain, and the researchers will compare how well each one works. This study is not yet recruiting participants, but it aims to help improve pain relief options for future patients having knee replacement surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who underwent total knee arthroplasty surgery
- • ASA I-II patients
- Exclusion Criteria:
- • Patient refusal to participate in the study
- • Patients with coagulopathy
- • Patients history with local anesthetic allergy or toxicity
- • Patients with liver and kidney failure
- • Mentally disabled patients
- • Presence of infection at the injection site
- • Pregnant, suspected pregnant, or breastfeeding mothers
About Bursa City Hospital
Bursa City Hospital is a premier healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a robust infrastructure, the hospital fosters collaboration between healthcare professionals and researchers to explore new therapies and treatment modalities. By participating in diverse clinical studies, Bursa City Hospital aims to contribute to the global medical community while ensuring the highest standards of safety and ethical practices in all research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported